Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.3.2018 | EN | Official Journal of the European Union | C 94/26 |

---

Order of the General Court of 22 January 2018 — Cristalfarma v EUIPO – Novartis (ILLUMINA)

(Case T-157/17)[(1)](#ntr1-C_2018094EN.01002602-E0001)

((EU trade mark - Opposition proceedings - Application for EU word mark ILLUMINA - Revocation of the contested decision - Action rendered devoid of purpose - No need to adjudicate))

(2018/C 094/35)

Language of the case: English

Parties

Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)

Defendant: European Union Intellectual Property Office (represented by: M. King and D. Gája, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: Novartis AG (Basle, Switzerland)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 (Case R 1187/2016-4), relating to opposition proceedings between Novartis and Cristalfarma.

Operative part of the order

|  |  |
| --- | --- |
| 1. | The request made by Cristalfarma Srl for a stay of the proceedings is rejected; |

|  |  |
| --- | --- |
| 2. | There is no longer any need to adjudicate on the action; |

|  |  |
| --- | --- |
| 3. | The European Union Intellectual Property Office (EUIPO) shall bear its own costs and pay those incurred by Cristalfarma; |

|  |  |
| --- | --- |
| 4. | Novartis AG shall bear its own costs. |

---

[Top](#document1)